Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India

Navi Mumbai Municipal Corporation (NMMC), a local government in Mumbai, India, implemented the first public sector TCV campaign in 2018. This study estimated the delivery costs of this TCV campaign using a Microsoft Excel-based tool based on a micro-costing approach from the government (NMMC) perspe...

Full description

Bibliographic Details
Main Authors: Dayoung Song, Sarah W. Pallas, Rahul Shimpi, N. Ramaswamy, Pradeep Haldar, Pauline Harvey, Pankaj Bhatnagar, Arun Katkar, Niniya Jayaprasad, Abhishek Kunwar, Sunil Bahl, Win Morgan, Raymond Hutubessy, Kashmira Date, Vittal Mogasale
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLOS Global Public Health
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022355/?tool=EBI
_version_ 1827828233382395904
author Dayoung Song
Sarah W. Pallas
Rahul Shimpi
N. Ramaswamy
Pradeep Haldar
Pauline Harvey
Pankaj Bhatnagar
Arun Katkar
Niniya Jayaprasad
Abhishek Kunwar
Sunil Bahl
Win Morgan
Raymond Hutubessy
Kashmira Date
Vittal Mogasale
author_facet Dayoung Song
Sarah W. Pallas
Rahul Shimpi
N. Ramaswamy
Pradeep Haldar
Pauline Harvey
Pankaj Bhatnagar
Arun Katkar
Niniya Jayaprasad
Abhishek Kunwar
Sunil Bahl
Win Morgan
Raymond Hutubessy
Kashmira Date
Vittal Mogasale
author_sort Dayoung Song
collection DOAJ
description Navi Mumbai Municipal Corporation (NMMC), a local government in Mumbai, India, implemented the first public sector TCV campaign in 2018. This study estimated the delivery costs of this TCV campaign using a Microsoft Excel-based tool based on a micro-costing approach from the government (NMMC) perspective. The campaign’s financial (direct expenditures) and economic costs (financial costs plus the monetized value of additional donated or existing items) incremental to the existing immunization program were collected. The data collection methods involved consultations with NMMC staff, reviews of financial and programmatic records of NMMC and the World Health Organization (WHO), and interviews with the health staff of sampled urban health posts (UHPs). Three UHPs were purposively sampled, representing the three dominant residence types in the catchment area: high-rise, slum, and mixed (high-rise and slum) areas. The high-rise area UHP had lower vaccination coverage (47%) compared with the mixed area (71%) and slum area UHPs (76%). The financial cost of vaccine and vaccination supplies (syringes, safety boxes) was $1.87 per dose, and the economic cost was $2.96 per dose in 2018 US dollars. Excluding the vaccine and vaccination supplies cost, the financial delivery cost across the 3 UHPs ranged from $0.37 to $0.53 per dose, and the economic delivery cost ranged from $1.37 to $3.98 per dose, with the highest delivery costs per dose in the high-rise areas. Across all 11 UHPs included in the campaign, the weighted average financial delivery cost was $0.38 per dose, and the economic delivery cost was $1.49 per dose. WHO has recommended the programmatic use of TCV in typhoid-endemic countries, and Gavi has included TCV in its vaccine portfolio. This first costing study of large-scale TCV introduction within a public sector immunization program provides empirical evidence for policymakers, stakeholders, and future vaccine campaign planning.
first_indexed 2024-03-12T03:48:03Z
format Article
id doaj.art-f89373e53177406b932232a262b3cc48
institution Directory Open Access Journal
issn 2767-3375
language English
last_indexed 2024-03-12T03:48:03Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLOS Global Public Health
spelling doaj.art-f89373e53177406b932232a262b3cc482023-09-03T12:43:03ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752023-01-0131Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, IndiaDayoung SongSarah W. PallasRahul ShimpiN. RamaswamyPradeep HaldarPauline HarveyPankaj BhatnagarArun KatkarNiniya JayaprasadAbhishek KunwarSunil BahlWin MorganRaymond HutubessyKashmira DateVittal MogasaleNavi Mumbai Municipal Corporation (NMMC), a local government in Mumbai, India, implemented the first public sector TCV campaign in 2018. This study estimated the delivery costs of this TCV campaign using a Microsoft Excel-based tool based on a micro-costing approach from the government (NMMC) perspective. The campaign’s financial (direct expenditures) and economic costs (financial costs plus the monetized value of additional donated or existing items) incremental to the existing immunization program were collected. The data collection methods involved consultations with NMMC staff, reviews of financial and programmatic records of NMMC and the World Health Organization (WHO), and interviews with the health staff of sampled urban health posts (UHPs). Three UHPs were purposively sampled, representing the three dominant residence types in the catchment area: high-rise, slum, and mixed (high-rise and slum) areas. The high-rise area UHP had lower vaccination coverage (47%) compared with the mixed area (71%) and slum area UHPs (76%). The financial cost of vaccine and vaccination supplies (syringes, safety boxes) was $1.87 per dose, and the economic cost was $2.96 per dose in 2018 US dollars. Excluding the vaccine and vaccination supplies cost, the financial delivery cost across the 3 UHPs ranged from $0.37 to $0.53 per dose, and the economic delivery cost ranged from $1.37 to $3.98 per dose, with the highest delivery costs per dose in the high-rise areas. Across all 11 UHPs included in the campaign, the weighted average financial delivery cost was $0.38 per dose, and the economic delivery cost was $1.49 per dose. WHO has recommended the programmatic use of TCV in typhoid-endemic countries, and Gavi has included TCV in its vaccine portfolio. This first costing study of large-scale TCV introduction within a public sector immunization program provides empirical evidence for policymakers, stakeholders, and future vaccine campaign planning.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022355/?tool=EBI
spellingShingle Dayoung Song
Sarah W. Pallas
Rahul Shimpi
N. Ramaswamy
Pradeep Haldar
Pauline Harvey
Pankaj Bhatnagar
Arun Katkar
Niniya Jayaprasad
Abhishek Kunwar
Sunil Bahl
Win Morgan
Raymond Hutubessy
Kashmira Date
Vittal Mogasale
Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India
PLOS Global Public Health
title Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India
title_full Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India
title_fullStr Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India
title_full_unstemmed Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India
title_short Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India
title_sort delivery cost of the first public sector introduction of typhoid conjugate vaccine in navi mumbai india
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022355/?tool=EBI
work_keys_str_mv AT dayoungsong deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT sarahwpallas deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT rahulshimpi deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT nramaswamy deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT pradeephaldar deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT paulineharvey deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT pankajbhatnagar deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT arunkatkar deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT niniyajayaprasad deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT abhishekkunwar deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT sunilbahl deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT winmorgan deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT raymondhutubessy deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT kashmiradate deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT vittalmogasale deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia